Spotlight On... Medidata stutters in attempt to recoup $4.8M in wire fraud losses; Medidata, Nestlé team up for health study; Illumina CEO to step down; and more...

A federal judge has refused to rule on a case stemming from the $4.8 million wire transfer fraud that was inflicted on Medidata ($MDSO) in 2014, Law360 reports. Medidata is trying to get its insurer to cover the losses. The judge wants more information before making a decision, telling the parties to come back with details of the method the fraudster used to send emails to Medidata. Article

> Medidata ($MDSO) teamed up with Nestlé to assess the effect of nutrition and physical activity on health. More

> Illumina ($ILMN) revealed Francis deSouza is to replace Jay Flatley as CEO of the company. News

> Facebook ($FB), Google ($GOOG) and Twitter ($TWTR) execs discussed how regulatory uncertainty is limiting biopharma participation on social media. Piece

> Metrics Champion Consortium partnered with goBalto to define benchmarks for study startup. Release

> Bloomberg profiled TrialReach, a software company that is trying to improve clinical trial recruitment. Article

Suggested Articles

APAC organizations are nearly five times slower than the global average to detect cyber intrusions (Image imaginima / iStockPhoto)
Biotech

Email hacker gains access to Sangamo's proprietary info

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

by Conor Hale
A doctor sitting at his desk working on a laptop computer.
CRO

AllTrials launches clinical trial results reporting tracker

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

by Angus Liu
DNA computer
CRO

DNAnexus launches NGS-based clinical trial solution

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

by Angus Liu